Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2022 Publisher: TEVA UK Limited, Brampton Road, Hampden Park, Eastbourne, East Sussex BN22 9AG, UNITED KINGDOM
Tymbrineb 300 mg/5 mL Nebuliser Solution.
| Pharmaceutical Form |
|---|
|
Nebuliser solution. Clear to slightly yellow solution. |
Each ampoule of 5 ml contains 300 mg tobramycin as a single dose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Tobramycin |
Tobramycin is an aminoglycoside antibiotic produced by Streptomyces tenebrarius. It acts primarily by disrupting protein synthesis leading to altered cell membrane permeability, progressive disruption of the cell envelope and eventual cell death. It is bactericidal at concentrations equal to or slightly greater than inhibitory concentrations. |
| List of Excipients |
|---|
|
Sodium chloride |
Tymbrineb Nebuliser Solution is supplied in 5 mL single-dose low density polyethylene ampoules.
4 ampoules are packed and sealed in a foil pouch. Each carton comprises 14 (56 ampoules), 28 (112 ampoules) or 42 (168 ampoules) foil pouches.
Not all pack sizes may be marketed.
TEVA UK Limited, Brampton Road, Hampden Park, Eastbourne, East Sussex BN22 9AG, UNITED KINGDOM
PL 00289/1437
22/12/2011
| Drug | Countries | |
|---|---|---|
| TYMBRINEB | Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
